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Abstract 62 
Partitioning of starter bacteria and enzyme activities were investigated at different 63 
stages of Cheddar cheese manufacture using three exogenous commercial enzyme 64 
preparations added to milk or at salting.  These enzymes included: Accelase AM317, 65 
Accelase AHC50, Accelerzyme CPG.  Flow cytometric analysis indicated that 66 
AHC50 or AM317 consisted of permeabilized or dead cells and contained a range of 67 
enzyme activities.  The CPG preparation only contained carboxypeptidase activity.  68 
Approximately 90% of the starter bacteria cells partitioned with the curd at whey 69 
drainage.  However, key enzyme activities partitioned with the bulk whey in the range 70 
of 22% to 90%.  An increased level of enzyme partitioning with the curd was 71 
observed for AHC50 which was added at salting indicating the mode of addition 72 
influenced partitioning.  These findings suggest that further scope exists to optimize 73 
both bacterial and exogenous enzyme incorporation into cheese curd to accelerate 74 
cheese ripening. 75 
76 
 4 
1. Introduction 77 
During Cheddar cheese manufacture starter lactococci are added to the milk for 78 
acidification and flavour development.  The starter microflora of Cheddar contributes 79 
to proteolysis through the action of cell-envelope proteinases (CEP) and released 80 
intracellular peptidases.  Other agents contributing to proteolysis include: residual 81 
plasmin and chymosin activities, non-starter lactic acid bacteria (NSLAB) and 82 
exogenous proteinase preparations (McSweeney, 2004).  As proteolysis is a rate-83 
limiting step in ripening it is important to maximise the contribution of the various 84 
proteolytic agents to positively influence flavour and texture development. In the case 85 
of starter lactococci, it is important to incorporate the maximal number of cells within 86 
the curd in order to provide the necessary balance of enzymes required for flavour 87 
development (Sheehan, O’Cuinn, FitzGerald, & Wilkinson, 2006).  In Cheddar cheese 88 
manufacture, whey is separated from the curd.  The pH of the curd at whey drainage 89 
has a significant role in determining compositional factors such as calcium content 90 
and retained chymosin activity.  At this point in the manufacturing process a 91 
partitioning of the starter microflora between the solid curd and the liquid bulk whey 92 
also occurs.  Despite the importance of this step in determining the degree of cell 93 
incorporation, published data is generally limited to direct plate counts (Bergamini, 94 
Hynes, Quiberoni, Suarez, & Zalazar, 2005; Dawson & Feagan, 1957; Jeanson, et al., 95 
2011; Romeih, Moe, & Skeie, 2012).  More recently, emerging technologies such as 96 
flow cytometry (FCM) have been used to gain an insight into various microbial sub-97 
populations of live, permeabilized and dead cells in cheese during ripening (Doolan & 98 
Wilkinson, 2009; Kilcawley, Nongonierma, Hannon, Doolan, & Wilkinson, 2012; 99 
Sheehan, O'Loughlin, O'Cuinn, FitzGerald, & Wilkinson, 2005).  Hence it would 100 
therefore be useful to utilise this technique to augment direct plate count data in any 101 
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new partitioning studies conducted during Cheddar cheese manufacture.  Acceleration 102 
of ripening time and/or flavour modification in Cheddar cheese has been undertaken 103 
in a number of studies involving addition of exogenous proteolytic preparations either 104 
with cheesemilk or at the salting stage (El Soda & Pandian, 1991; Hannon, et al., 105 
2003; Kailasapathy & Lam, 2005; Madkor, Tong, & El Soda, 2000; Wilkinson, 106 
Guinee, O'Callaghan, & Fox, 1992).  A key factor in accelerating proteolysis is 107 
ensuring maximum incorporation of starter lactococci and added exogenous enzymes 108 
into the curd on the day of manufacture.  In the case of coagulant added to milk for 109 
cheese manufacture estimated losses in the whey at drainage are of the order 85-94% 110 
(Bansal, Fox, & McSweeney, 2007; Garnot, Molle, & Piot, 1987; Holmes, Duersch, 111 
& Ernstrom, 1977).  Holmes, et al. (1977) reported distribution of milk clotting 112 
enzymes as; 83% in bulk whey and 17% in bulk curd while after overnight curd 113 
pressing only 6% of the original activity remained.  However, such detailed studies 114 
are lacking in the case of added exogenous proteinases for accelerated ripening.  This 115 
information would be of benefit to cheese manufacturers to better understand the 116 
degree of enzyme incorporation that occurs when enzymes are added with milk or to 117 
curd at salting.  The objectives of this study were to investigate the partitioning of 118 
starter lactococci during normal cheese manufacture and added key activities in 119 
exogenous commercial enzyme preparations added to cheese milk or at salting. 120 
 121 
2. Material and methods 122 
2.1. Cheese making strains and cheese manufacture 123 
Control or experimental cheeses were manufactured in triplicate as described by 124 
Kilcawley, et al. (2012).  In each trial, control cheeses or those with added exogenous 125 
enzyme preparations were rotated into different vats on each day of cheesemaking to 126 
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avoid any possible contribution from vat-related factors.  Accelase AM317 (Danisco, 128 
Dange-Saint-Romain, France) and Accelerzyme CPG (DSM Food Specialties, 129 
B.V,Delft, The Netherlands) were added to cheese milk while Accelase AHC50 130 
(Danisco) was added with the salt as described by Kilcawley et al., (2012).  131 
At the following points during manufacture cheeses were sampled for microbiology, 132 
flow cytometry (FCM), enzymology and proteolysis: cheesemilk after inoculation 133 
(A1), bulk whey at drainage (B1), bulk curd at drainage (B2), whey after salting (C1), 134 
curd after salting (C2) and whey after pressing (D1).  Parameters also monitored 135 
during manufacture included curd yield and total production time as an average of the 136 
three trials. 137 
 138 
2.2. Microbiological analysis 139 
L-M17 agar was used to determine the plate counts of starter culture during 140 
manufacture of the cheeses (Terzaghi & Sandine, 1975).  Milk or whey samples were 141 
analysed by directly diluting with maximum recovery diluent (MRD) while curd 142 
samples were prepared by diluting 1/10 (w/v) with sterile tri-sodium citrate (2% w/v) 143 
and homogenized for 5 min using a stomacher (Seward Medical, London, UK).  144 
Microbiological analysis was carried out in duplicate at each sampling point and L-145 
M17 agar plates were incubated at 30°C for 3 days. 146 
 147 
2.3. Activities in exogenous proteinase preparations prior to cheese manufacture 148 
2.3.1. Azocasein activity 149 
General endoproteinase activity in the commercial enzyme preparations was 150 
determined using an azocasein assay (Kilcawley, Wilkinson, & Fox, 2002).  The 151 
enzyme preparations were appropriately diluted in 0.05 M phosphate buffer pH 7.0, 152 
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on a volume basis (v/v) for CPG, and on a weight basis (w/v) for both AM317 and 153 
AHC50.  Each assay was performed in quadruplicate.  Activity was expressed as the 154 
change in absorbance.min
-1
.mg
-1
 protein under the assay conditions. 155 
 156 
2.3.2. Peptidase activities 157 
Commercial enzyme preparations were analysed for a range of peptidase activities 158 
using different 7-amino-4-methyl coumarin (AMC) substrates (Table 2) at pH 7.0 159 
(0.05 M Tris-HCl) or pH 5.2 (0.05 M citrate phosphate buffer) by modifications of the 160 
methods described by Habibi-Najafi and Lee (1994), Kilcawley, et al. (2002) and 161 
Kilcawley, et al. (2012).  The release of AMC was calculated by reference to the 162 
standard curve where the fluorescence of the sample was converted to nmol of AMC.  163 
Activity was expressed as nmol min
-1
 .mg
-1
 protein. 164 
 165 
2.3.3. Esterase activity 166 
Esterase activity was measured in triplicate at pH 7.0 in 50 mM phosphate buffer at 167 
pH 5.0 in a 0.1 M trisodium citrate buffer using p-nitrophenyl butyrate as described 168 
by Hickey, Kilcawley, Beresford, Sheehan & Wilkinson (2006).  A unit (U) of 169 
activity was defined as the amount of enzyme that released 1 mM of p-nitrophenol 170 
min 
-1 
.mg
-1
 protein under the assay conditions. 171 
 172 
2.3.4. Lipase activity 173 
Lipase activity was measured according to the method of Stead (1983) with the 174 
following modifications: a volume of 180 L of sample was used and 3 mL of either 175 
0.1 M Tris-HCl, pH 8.0 or a 0.1 M trisodium citrate buffer, pH 5.0.  The substrate 176 
consisted of 300 µL of a 16.6 mM solution of 4-methylumbelliferyl oleate (Sigma 177 
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Aldrich). The samples were incubated at 37C and fluorescence was measured over a 179 
30 min period at an excitation and emission wavelength of 325 and 450 nm, 180 
respectively using a Varian Cary Eclipse with Pelletier (Varian, JVA Analytical Ltd.), 181 
With each sample, a blank consisting of 0.1 M Tris-HCl at pH 8.0 was used instead of 182 
the sample to take account of any background fluorescence.  A standard curve 183 
(R
2
=0.991) was generated in the range 0 to 20 mM 4-methylumbelliferone (the 184 
primary product of the enzymatic reaction) prepared in the same manner as the 4-185 
methylumbelliferyl oleate solution.  Activity was expressed in units, where one unit 186 
(U) equalled the activity required to produce 1 pM of 4-methylumbelliferone .s
-1 
.mg
-1 
187 
protein under the assay conditions. 188 
 189 
2.3.5. Carboxypeptidase activity (Alanine substrate) 190 
Carboxypeptidase was determined using a modification of the method of  (Doi, 191 
Shibata, & Matoba, 1981) where alanine (Ala) was released from the substrate Z-Phe-192 
Ala (Bachem, Feinchemikalien, Bubendorf, Switzerland).  Alanine released formed a 193 
complex with cadmium-ninhydrin with an absorbance maximum at 506 nm.  An 194 
increase in absorbance was quantified from a standard curve produced using 195 
concentrations of alanine (in the range 0.1, 0.2, 0.5, 0.8, 1.0 to 2.0 mM; R
2
=0.997) 196 
added to a test mixture of cadmium-ninhydrin.  Absorbance at 506 nm was detected 197 
using a Varian Cary Bio 100 spectrophotometer (JVA Analytical Ltd).  198 
Carboxypeptidase activity was expressed as mM of Ala released. min
-1
 .mg
-1
 protein 199 
and was determined at pH 5.0 (0.1 M trisodium citrate buffer) or pH 7.0 (0.05 M Tris-200 
HCl). 201 
 202 
2.3.6. Carboxypeptidase activity (Leucine substrate). 203 
 9 
Carboxypeptidase activity was measured at pH 3.2 and pH 5.0 (0.1 M trisodium 204 
citrate buffer) and pH 7.0 (0.05 M Tris-HCl) using a modification of the method of 205 
Hurley, O'Driscoll, Kelly, and McSweeney (1999) as described by Kilcawley, et al. 206 
(2012).  Carboxypeptidase activity was expressed as nM of heptapeptide degraded. 207 
min
-1
 .mg
-1
 protein under the assay conditions. 208 
 209 
2.4. Enzyme activities in the bulk whey and curd during cheese manufacture 210 
2.4.1. Preparation of the curd extracts and whey samples 211 
Curd extracts were analysed during manufacture for various enzyme activities.  Fresh 212 
curd (20 g) collected on the day of production was mixed with 40 mL of 0.05 M 213 
potassium phosphate buffer at pH 7.0 in a sterile stomacher bag.  The sample was 214 
homogenised in a Stomacher (IUL masticator, Lennox Laboratory Supplies Ltd, 215 
Dublin, Ireland) for 5 min or until completely homogenous.  A 10 mL aliquot of the 216 
mixture was centrifuged at 4°C for 10 min at 10,000 g (Sorvall 5U centrifuge, 217 
Unitech, Dublin, Ireland).  Then 1 mL of the resultant supernatant was added to an 218 
eppendorf tube and centrifuged at 13,000 g for 5 min (Eppendorf 5417C, VWR 219 
International, Dublin, Ireland).  The final supernatant was diluted as required and 220 
subsequently assayed for various enzyme activities described above.  Whey samples 221 
were directly diluted using the appropriate buffer for the particular enzyme assay.  All 222 
enzyme assays were carried out in triplicate for each cheese trial on the three different 223 
days of manufacture. 224 
In the control cheese, Pep X or Pep N activities were monitored at all six sampling 225 
points (A1, B1, B2, C1, C2 and D1) while all other enzyme activities were determined 226 
in the bulk whey and bulk curd (B1 and B2) only.  In experimental cheeses, enzyme 227 
activities were monitored in the whey or curds after the addition of the exogenous 228 
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enzymes.  For cheeses made with added AM317 or CPG, enzyme activities were 230 
monitored in the bulk curd and bulk whey at drainage (B1 and B2, respectively).  In 231 
the case of cheeses with added AHC50 this preparation was added at salting and 232 
consequently activities were monitored in the salted curd and salted whey (C1 and C2, 233 
respectively). 234 
 235 
2.4.2. Enzyme activities in curd extracts and whey samples on day of manufacture 236 
Enzyme activities present in the curd and whey samples were measured as per the 237 
methods described in section 2.3.  In order to determine the partitioning of these 238 
enzymatic activities to the curd and whey respectively, the total volumes of the bulk 239 
curd, bulk whey, salted curd and salted whey were weighed (kg) and activities present 240 
in each sample was determined as a percentage of total activity. The total enzyme 241 
activity in the curd and whey in each cheese was calculated using the average 242 
volumes of curd and whey weighed on each day of manufacture.  These are detailed 243 
in Table 1. 244 
 245 
2.5. Flow Cytometry of curd and whey samples during cheese manufacture 246 
Prior to cytometric analysis, whey or milk samples were diluted appropriately using 247 
0.05 M potassium phosphate buffer pH 7.0 and immediately stained and analysed as 248 
described by Kilcawley, et al. (2012). 249 
 250 
2.6. Free amino acid analysis 251 
Individual free amino acids (FAA) were determined on 24% TCA filtrates prepared 252 
directly from the bulk whey or from a pH 4.6 water soluble nitrogen fraction of the 253 
bulk curd as described by (Kuchroo & Fox, 1982).  Duplicate samples were analysed 254 
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using a Jeol JLC-500/V Amino Acid Analyzer (Jeol Ltd, Garden City, Herts, UK) 256 
fitted with a Jeol sodium high performance cation exchange column.  Results were 257 
expressed as μg .g-1 cheese or whey. 258 
 259 
2.7. Statistical analysis 260 
Presentation of data was carried out using Microsoft® Excel.  For the determination 261 
of the accelerated ripening preparations enzyme activities, the experimental design 262 
was a 3×2 factorial design, enzyme×pH.  A 2 way ANOVA followed by a Student 263 
Newman-Keuls post-hoc test (P<0.05) was carried out with SPSS (version 9, SPSS 264 
Inc., Chicago, IL, USA).  For the determination of the enzyme activities during cheese 265 
production, 3 accelerated ripening preparations and one control were studied, 266 
therefore a one way ANOVA was used for statistical analysis, followed by a Student 267 
Newman-Keuls post-hoc test (P<0.05) with SPSS.  Two-way ANOVA analysis with 268 
the Tukey’s significance difference test (P<0.05) was used for the analysis of FCM 269 
data.  R (2011) software was used for statistical analysis (Development Core Team, 270 
2011). 271 
 272 
3. Results and Discussion 273 
3.1. Enzyme activities of the accelerated ripening preparations 274 
Peptidase activities detected in the three exogenous commercial preparations are 275 
presented in Table 1.  Of the twelve substrates examined, substantial Pep X activity 276 
was detected in both AM317 and AHC50 preparations and was higher at pH 7.0 277 
compared with pH 5.2 for both preparations.  In contrast, Accelerzyme CPG 278 
contained very little activity against the range of substrates tested, except for Pep R 279 
which was detectable only at pH 5.2 (Table 1).  Both AHC50 and AM317 280 
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preparations had similar levels of activity towards the Z-Phe-Ala substrate which were 281 
significantly higher (P<0.05) at pH 7.0 (Table 2).  The CPG preparation displayed 282 
little activity against the Z-Phe-Ala substrate and could only release low levels of 283 
alanine from this peptide.  However, CPG displayed the highest activity of the three 284 
enzyme preparations against the heptapeptide substrate Pro-Thr-Glu-Phe-[NO2-Phe]-285 
Arg-Leu, which may indicate carboxypeptidase activity (Table 2).  This activity was 286 
~10 fold greater for the CPG preparation compared with AM317 or AHC50 at pH 3.2 287 
and 5.0, but was similar to the other two commercial enzyme preparations at pH 7.0 288 
(Table 2). 289 
Overall, proteolytic activities for each preparation towards the azocasein substrate at 290 
pH 5.0 or 7.0 were always significantly higher (P<0.05) for AM317 than the AHC50 291 
preparation, with no activity detected for the CPG preparation (Table 3).  For all three 292 
enzyme preparations, esterase activity was significantly higher in both AM317 and 293 
AHC50 preparations.  This activity was also significantly higher (P<0.05) at pH 5.0 294 
compared with pH 7.0 (Table 2).  Lipase activity was significantly higher (P<0.05) in 295 
AM317 compared with the two other preparations and, in contrast to esterase activity, 296 
was highest at pH 5.0 for the latter enzyme preparation (Table 2).  These results 297 
highlight a major difference in the range of enzyme activities contained in the CPG 298 
preparation in comparison to AM317 or AHC50 preparations. 299 
 300 
3.2. Cheese manufacturing 301 
Cheeses manufactured with added AM317 had coagulation times of 36.33 min 302 
compared with control cheeses (40.00 min), while cheeses made with CPG or AHC50 303 
had somewhat extended coagulation times of 43.67 and 46.67 min, respectively.  304 
Total curd yields for all cheeses ranged from 47.3 to 49.5 kg per 454 L of cheese 305 
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milk.  Overall, Control or AM317 cheeses had the shortest manufacturing times, but 310 
all cheeses were manufactured within times (from addition of starter until pre-press) 311 
ranging from 328 to 343 min (data not shown), which were not statistically significant 312 
(P≥0.05). 313 
 314 
3.3. Microbiological analysis 315 
The viable starter counts on L-M17 agar for all cheeses at each sampling point over 316 
triplicate manufacturing trials were calculated.  Overall, an increase in cell numbers 317 
was observed in the bulk curd samples for all cheeses corresponding to cell growth 318 
and pH development.  For all cheeses an increase in starter populations was observed 319 
between the bulk curd after drainage and the salted curd.  The only statistically 320 
significant difference (P<0.05) in LAB starter counts was found in the bulk curd 321 
samples at whey drainage where higher populations were noted for cheese with added 322 
AM317 compared with cheese with added CPG preparation. 323 
The calculated percentages of starter bacteria partitioning between the bulk curd and 324 
bulk whey and subsequently between the salted curd and the salted whey are shown in 325 
Fig. 1.  The calculated percentage retention of starter bacteria in the bulk curd for 326 
Control or AHC50 cheeses was 94.7% or 91.9%, respectively.  In contrast, retention 327 
of starter bacteria in AM317 or CPG-treated cheeses was 88.8% or 81.5%, 328 
respectively (Fig. 1a).  This finding appears in general agreement with that reported 329 
by (Jeanson, et al., 2011) who stated that~90%, of starter cells preferentially partition 330 
with the curd.  These workers also highlighted the importance of final curd numbers 331 
in terms of spatial distribution and possible influences on diffusion of solutes and 332 
enzymes to and from starter cells during ripening.  It has been postulated by Laloy, 333 
Vuillemard, El Soda, and Simard (1996) that bacteria may partition with the curd 334 
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based on an affinity for the milk fat globule membrane.  At salting an average ~99% 337 
retention of starter was calculated for all cheeses with ~1% losses of cells in the salted 338 
whey (Fig. 1b). 339 
 340 
3.4. Pep X and Pep N activities during cheese production 341 
Pep X and Pep N activities of AHC50-treated cheese were considered to be similar to 342 
the control as this preparation was not added to the cheesemilk.  Activity of Pep X or 343 
Pep N detected in Control samples may have originated from early autolysis of starter 344 
culture during cheese production (Table 33).  For all cheeses, Pep X activity was 345 
significantly (P<0.05) higher than Pep N activity in the bulk curd and bulk whey.  346 
Additionally, Pep X activity in the bulk curd was not significantly different (P≥0.05) 347 
between any of the cheeses and the calculated partitioning to the bulk whey was 348 
similar (~67%) for all cheeses.  For Pep N activity, 21 or 35% partitioned with the 349 
bulk whey for AM317 or CPG treated cheeses, respectively.  The differences in 350 
enzyme partitioning to the bulk whey observed between Pep X and Pep N may be due 351 
to differences in enzyme stability, conformation, affinity with the cheese matrix and 352 
accessibility of required co-factors. 353 
No significant differences (P≥0.05) in Pep N activity were observed in bulk whey or 354 
bulk curd between any of the cheeses (Table 3).  At salting, partitioning of Pep X and 355 
Pep N to the whey in the Control cheese was relatively low (<2%, Table 3).  In the 356 
cheeses with added AHC50, the levels of Pep X in the salted curd was significantly 357 
higher (P<0.05) when compared with control cheeses.  In AHC50-treated cheeses, 358 
95.1 or 90.3% of Pep X and Pep N partitioned with the salted curd, respectively.  359 
Partitioning of these activities with the salted whey/ pressed whey were lower for 360 
AHC50 cheese compared with AM317 or CPG-treated cheeses.  Overall this data 361 
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supports the general idea that addition of enzyme preparation with salt can reduce 367 
partitioning of enzyme with the whey (Wilkinson & Kilcawley, 2005).  The higher 368 
Pep X levels seen in the salted whey of AHC50 cheeses may be attributed to the mode 369 
of addition of the AHC50 preparation which was added to the salt. 370 
 371 
3.5. Other enzyme activities (carboxypeptidase, esterase and lipase) in the whey 372 
and curd 373 
In all cheeses a comparison of other enzyme activities monitored indicated no 374 
significant difference (P≥0.05) in activities partitioning with the bulk curd or bulk 375 
whey (Table 4).  Significantly higher lipase activity was found in the bulk curd 376 
compared to the bulk whey (Table 5).  Carboxypeptidase and esterase activities were 377 
not significantly higher (P≥0.05) in the bulk whey compared to the bulk curd, except 378 
for carboxypeptidase activity against Leucine substrate in AM317-treated cheeses 379 
(Table 4).  Lipase activities displayed the opposite trend with higher activity 380 
partitioning with the bulk curd (P<0.05).  Partitioning of carboxypeptidases and 381 
esterases activities with bulk whey was relatively high ranging from 67.3 to 90.5 %.  382 
These values are in accordance with Wilkinson and Kilcawley (2005) who reviewed 383 
the area and noted that some studies reported partitioning of enzymes to the bulk 384 
whey at drainage may be as high as 90%.  Partitioning of lipase activity with the whey 385 
was lower with values ranging from 44.2 to 49.7%. 386 
 387 
3.6 Flow cytometric analysis of starter cells on day of manufacture 388 
Dot plots were generated at all sampling points for each of the cheeses and data were 389 
expressed as a percentage of live, permeabilized or dead cells (Fig. 2).  Significant 390 
differences (P≥0.05) in live cells were not evident between cheeses at any sampling 391 
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point (Table 5).  However, in the AHC50-treated cheeses levels of permeabilized or 393 
dead cells were significantly different (P<0.05) in the salted whey and pressed whey 394 
in comparison to the other cheeses.  Previous FCM data found that the AHC50 395 
preparation contained primarily permeabilized/dead cells (Kilcawley, et al., 2012).  396 
These cells may have been generated following an attenuation treatment as the 397 
cytometric profiles were similar to those obtained following CTAB treatment of 398 
lactococcal strains observed by Doolan and Wilkinson (2009) and Sheehan, et al. 399 
(2005).  Thus, it appears that most of the permeabilized/dead cells in the AHC50 400 
preparation were lost to the salted and pressed whey immediately after addition.  It is 401 
possible that in the case of AHC 50, the original cells may have been exposed to 402 
treatments which may have removed cell surface components associated with 403 
electrostatic attraction and incorporation into the curd matrix.  Indeed, Crow, Gopal, 404 
and Wicken (1995) noted that treatments which altered the cell surface components of 405 
a range of starter strains but which did not cause autolysis resulted in differing 406 
degrees of hydrophobicity and phage adsorption.  While these authors did not link 407 
these effects with cell partitioning in cheese manufacture, it is reasonable to postulate 408 
that the type of permeabilising treatments used for AHC 50 manufacture may have 409 
also impacted on cell surface architecture and partitioning properties.  Doolan and 410 
Wilkinson (2009) noted that significant treatment-related effects on cell permeability 411 
and intracellular enzyme release, howover in the case of AHC 50 this information is 412 
not available.  Therefore while an industrial process may have been optimised to 413 
enhance cell permeability and intracellular enzyme release it may have adversely 414 
affected cell surface properties and consequent retention during cheese manufacture. 415 
 416 
3.7. Free amino acid analysis 417 
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Total FAA levels were significantly (P<0.05) higher in the bulk whey of the AM317-423 
treated cheeses compared to the other cheeses and was more than double that of the 424 
other cheeses (Fig. 3).  The individual FAA profile of the bulk whey of the AM317 425 
cheeses was also very different to that of the other cheeses.  However, Pep X and Pep 426 
N activities in the bulk whey of the AM317-treated cheeses were not significantly 427 
(P≥0.05) higher than in the other cheeses.  Hence differences in total FAA levels may 428 
be due to higher levels of proteolytic activity contained in the AM317 preparation 429 
(Table 2) and which may have a different substrate specificity compared with 430 
chymosin.  Such enzymatic differences could account for differences in FFA levels 431 
generated and in individual FAA profiles.  As the CPG preparation did not contain 432 
any proteinase activity and the AHC50 preparation was added with the salt, levels of 433 
FAA in the bulk whey from both these cheeses should not differ from each other in 434 
the bulk whey.  Although the additional losses of FAA in the bulk whey of AM317 435 
cheeses did not impact on yield it may impact on the potential downstream processing 436 
applications for this whey.  The extent of partitioning with the bulk whey found for 437 
commercial enzymes represents an adverse economic outcome in terms of cost 438 
benefits to cheese manufacturers.  Therefore further optimisation of methods for the 439 
addition of exogenous enzyme preparations in cheese manufacture are still required to 440 
achieve the most cost effective outcomes. 441 
 442 
4.0 Conclusion 443 
In this study, cheese was produced using commercial enzyme preparations marketed 444 
as accelerated ripening agents.  Pre-screening of these preparations prior to their use 445 
identified CPG as a relatively pure preparation with minimal enzymatic side enzyme 446 
activities present.  However, both the AM317 and AHC50 preparations contained a 447 
Deleted:  448 
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range of enzymatic activities and previous studies by Kilcawley, et al. (2012) have 450 
shown that these preparations consist primarily of permeabilized and dead bacterial 451 
cells.  During Cheddar cheese production, approximately 90% of the starter cells 452 
partitioned with the bulk curd after whey drainage.  Significant partitioning of enzyme 453 
activities with the bulk whey was observed ranging from 22 to 90% of the added 454 
initial levels.  Lowest partitioning with the whey was noted for Pep N activity and 455 
highest for esterase and carboxypeptidase activities.  In the cheese where the enzyme 456 
preparation was added with the salt (AHC50), partitioning of Pep X and Pep N 457 
activity to the salted curd was 95.2 and 90.3%, respectively, when the volumes of 458 
salted whey and salted curd were taken into account.  Overall it would appear that the 459 
addition of exogenous enzyme preparations with the salt rather than to the cheesemilk 460 
may significantly improve their retention.  Free amino acid analysis of bulk whey 461 
samples revealed high levels of FAA in the bulk whey from cheese treated with 462 
AM317, which may impact on the suitability of such whey for certain applications.  463 
This study has provided useful information on partitioning of both starter bacteria and 464 
added exogenous enzymes in the curd and whey during manufacture of potential 465 
interest to enzyme manufacturers and cheese producers alike. 466 
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Table 1.  Peptidase activities of the commercial accelerated ripening systems at pH 5.2 and 7.0.  Values presented are the mean±SD of triplicate 476 
trials. 477 
 478 
Substrate Peptidase Activity (nmol min
-1
 mL
-1
) Mean±SD 
AM317 Accelerzyme CPG AHC50 
  pH 7.0 pH 5.2 pH 7.0 pH 5.2 pH 7.0 pH 5.2 
Pep N H-Lys-AMC 8.4±0.0 0.0±0.0 0.1±0.1 0.2±0.0 5.6±4.9 0.0±0.0 
Pep X H-Gly-Pro-AMC 940.1±79.5 587.33±44.86 0.0±0.0 0.3±0.0 1598.9±164.2 669.5±85.1 
Pep A (1) H-Asp-AMC 5.6±4.7 0.0±0.0 0.1±0.0 0.1±0.0 2.8±4.9 6.4±11.2 
Pep A (2) H-Glu-AMC 20.8±6.2 0.0±0.0 0.0±0.0 0.3±0.0 10.5±3.6 0.0±0.0 
Pep M H-Met-AMC 0.0±0.0 0.0±0.0 0.3±0.0 0.15±0.03 0.0±0.0 0.0±0.0 
Pep R Z-Pro-Arg-AMC-HCl 7.7±7.3 0.0±0.0 0.2±0.0 25.9±4.5 7.7±7.3 0.0±0.0 
Pep Q Z-Gly-Pro-AMC 14.6±6.2 0.0±0.0 0.0±0.0 0.3±0.0 0.0±0.0 15.4±3.4 
Pep I H-Pro-AMC 0.0±0.0 0.0±0.0 0.1±0.0 0.1±0.1 9.7±8.5 12.9±12.6 
 479 
 480 
481 
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Table 2.  Carboxypeptidase, Esterase, Lipase and Azocasein activities of the commercial accelerated ripening systems at different pH values.  482 
Values presented are the mean±SD of triplicate trials. 483 
 484 
  Mean activity ±SD 
Enzyme assay pH AM317 Accelerzyme CPG AHC50 
Carboxypeptidase- Ala 
substrate (mM/min/mg) 
5.0 251.0±21.7
b
 14.7±1.4
a
 235.3±11.3
b
 
7.0 531.1±4.5
c
 19.9±0.5
a
 521.8±31.6
c
 
Carboxypeptidase- Leu 
substrate (mM/min/mg) 
3.2 4.0±0.1
c
 39.7±0.1
e
 1.6±0.1
a
 
5.0 3.1±0.1
b
 39.7±0.1
e
 1.9±0.4
a
 
7.0 4.8±0.1
d
 5.7±0.8
d
 5.4±0.1
d
 
Esterase (µM/min) 5.0 1949.7±10.7
d
 209.5±19.7
c
 1914.8±32.7
d
 
7.0 122.7±8.3
b
 24.6±1.7
a
 50.4±8.6
a
 
Lipase (pM/s/mg) 5.0 44.0±13.5
c
 0.3±0.1
a
 1.2±0.2
a
 
8.0 26.7±3.8
b
 0.3±0.1
a
 1.4±0.2
a
 
Azocasein (OD/min/mg) 5.0 0.8±0.1
b
 nd 0.3±0.1
a
 
7.0 2.8±0.1
d
 nd 1.2±0.1
c
 
 485 
nd not detected 
486 
 487 
 488 
 489 
490 
Formatted: French (France)
Formatted: English (Ireland)
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Table 3.  Pep X and Pep N activities (per mL of whey or per g of curd) during production (±SD of triplicate trials). Bulk whey (B1), bulk curd 491 
(B2), salted whey (C1) and salted curd (C2)  492 
 Pep N activity Pep X activity Pep N activity Pep X activity 
 B1* B2* Partition 
to the 
whey% 
B1* B2* Partition 
to the 
whey% 
C1* C2* Partition 
to the 
whey% 
C1* C2* Partition 
to the 
whey% 
Control 0.00±0.0
a 
0.14±0.089
a 
0 0.43±0.03
a 
1.68±0.36
a 
68.2 0.63±0.06
a 
0.25±0.08
a 
1.48 0.45±0.08
a 
3.53±1.00
a 
0.16 
AM317 0.00±0.0
a 
0.09±0.11
a 
21.4 0.46±0.09
a 
1.92±0.83
a 
67.4 nd nd
 
nd nd
 
nd
 
nd 
CPG 0.00±0.0
a 
0.06±0.06
a 
35.3 0.42±0.10
a 
1.75±1.04
a 
66.8 nd nd
 
nd nd
 
nd
 
nd 
AHC50 nd nd
 
nd nd
 
nd
 
nd 4.60±4.75
a 
0.53±0.46 9.7 1.76±1.33
a 
1.28±0.39
b 
4.9 
 
493 
Values presented are the mean±SD of triplicate trials 
494 
n.d.: not determined  
495 
*In the same column, figures with the same letter are not significantly different (P≥0.05)  
496 
Abbreviations: Pep N, aminopeptidase N; Pep X, Post-prolyl di-peptidyl aminopeptidase X; B1, Bulk whey; B2, Bulk Curd, Activity;  Enzyme activity;  Partition to the whey , % enzyme partitioned to the whey. 
497 
 
498 
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Table 4. Carboxypeptidase, chymosin, esterase, and lipase activity (±SD of triplicate trials) in the bulk whey (B1) and bulk curd (B2) of the 499 
control, CPG and AM317 cheeses. Enzyme activities are expressed per mL of whey or per g of curd. 500 
 501 
Values presented are the mean±SD of triplicate trials 
502 
n.d.: not determined  
503 
*Within the same enzyme activity, figures with the same letter are not significantly different (P≥0.05) 
504 
Abbreviations: Ala substrate, Z-Phe-Ala; Leu substrate, Pro-Thr-Glu-Phe-[NO
2
-Phe]-Arg-Leu; Activity, enzyme activity; B1, Bulk Whey; B2, Bulk Curd; Partition to the whey , % enzyme partitioned to the whey.
 505 
 
Carboxypeptidase 
(Ala substrate) 
 
Carboxypeptidase 
(Leu substrate) 
 
Esterase Lipase 
 
Activity (mM/min) Partition 
to the 
whey (%) 
Activity (nM/min) 
 
Partition 
to the 
whey (%) 
Activity (nM/min) 
 
Partition 
to the 
whey (%) 
Activity (pM/s) 
 
Partition 
to the 
whey (%)  B1* B2* B1* B2* B1* B2* B1* B2* 
Control 0.06±0.01a 0.04±0.01a 90.5 7.6±2.0a 14.8±13.4a,b 
 
81.2 100.6±39.4a 138.0±136.9a 67.2 65.6±13.8a 559.5 ± 434.6b 49.7 
CPG 0.06±0.02a 0.05±0.03a 84.1 n.d. n.d. n.d. 127.4±19.3a 150.8±128.5a 70.3 64.9±7.8a 592.5±191.2b 48.1 
AM317 0.08±0.02
a
 0.06±0.03a 86.2 9.1±2.9a 21.3±1.0b 77.8 n.d. n.d. n.d. 65.2±5.8a 669.1±278.5b 44.2 
23 
 
Table 5. Percentage of cells detected by Flow Cytometry for each of the regions: live, permeabilized, or dead for control or experimental 506 
cheeses at each of the sampling points: After inoculation (A1), Bulk Whey (B1), Bulk Curd (B2), Salted whey (C1), Salted curd (C2) and 507 
pressed whey (D1). 508 
 509 
Region Cheese A1*
 
B1* B2* C1* C2* D1* 
Live CTL 26.6±7.7
a 
28.0±13.2
 a
 17.2±6.3
 a
 29.2±7.8
 a
 17.3±7.1
 a
 37.3±19.7
 a
 
AM317 22.0±12.1
 a
 23.5±11.6
 a
 24.6±15.5
 a
 33.5±11.8
 a
 14.1±6.2
 a
 28.1±13.6
 a
 
CPG 22.2±13.6
 a
 21.3±12.7
 a
 15.2±5.2
 a
 34.5±22.2
 a
 13.5±5.4
 a
 35.3±22.4
 a
 
AHC50 18.3±8.0
 a
 23.9±13.6
 a
 16.0±5.1
 a
 7.1±3.1
 b
 15.1±7.6
 a
 11.3±6.4
 a
 
       
Permeabilized 
 
CTL 26.0±0.6
 a
 12.9±1.4
 a
 23.9±5.6
 a
 14.5±1.6
 a
 21.2±5.8
 a
 12.7±1.0
 a
 
AM317 26.3±7.8
 a
 13.2±3.9
 a
 37.1±16.1
 a
 14.1±2.3
 a
 24.2±9.9
 a
 14.3±7.0
 a
 
CPG 22.4±2.5
 a
 14.3±2.8
 a
 29.8±11.2
 a
 12.7±1.3
 a
 33.0±15.6
 a
 12.9±3.0
 a
 
AHC50 25.4±8.0
 a
 13.9±0.9
 a
 31.2±7.8
 a
 5.8±2.2
 b
 31.0±5.6
 a
 5.9±1.3
 b
 
       
Dead CTL 44.5±8.6
 a
 63.6±12.1
 a
 58.5±9.0
 a
 53.9±9.0
 a
 62.1±11.8
 a
 55.6±17.9
 a
 
AM317 62.3±15.2
 a
 49.1±20.20
 a
 45.6±30.4
 a
 52.9±10.5
 a
 62.2±12.8
a
 57.5±13.0
 a
 
CPG 54.1±10.9
 a
 64.8±8.9
 a
 54.8±13.5
 a
 50.6±19.1
 a
 52.2±18.4
 a
 48.7±17.9
 a
 
AHC50 46.6±20.4
 a
 63.8±10.0
 a
 53.9±10.7
 a
 80.2±4.70
b
 53.9±10.0
 a
 84.4±5.4
b
 
 
510 
Values presented are the mean±SD of triplicate trials 
511 
*Within the same column, figures with the same letter are not significantly different (P≥0.05) 
512 
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